| 20-01-2022 |
de Jonge Investments |
Karyopharm Therapeutics Inc. - Common Stock |
23 |
$115.95 |
$2,666.85 |
| 21-01-2022 |
de Jonge Investments |
Karyopharm Therapeutics Inc. - Common Stock |
-23 |
$124.20 |
-$2,856.60 |
| 10-02-2022 |
de Jonge Investments |
Karyopharm Therapeutics Inc. - Common Stock |
31 |
$136.65 |
$4,236.15 |
| 11-02-2022 |
de Jonge Investments |
Karyopharm Therapeutics Inc. - Common Stock |
-31 |
$153.30 |
-$4,752.30 |
| 17-02-2022 |
de Jonge Investments |
Karyopharm Therapeutics Inc. - Common Stock |
33 |
$180.00 |
$5,940.00 |
| 18-02-2022 |
de Jonge Investments |
Karyopharm Therapeutics Inc. - Common Stock |
-33 |
$215.70 |
-$7,118.10 |
| 22-02-2022 |
de Jonge Investments |
Karyopharm Therapeutics Inc. - Common Stock |
46 |
$154.35 |
$7,100.10 |
| 23-02-2022 |
de Jonge Investments |
Karyopharm Therapeutics Inc. - Common Stock |
-46 |
$157.50 |
-$7,245.00 |
| 22-03-2022 |
de Jonge Investments |
Karyopharm Therapeutics Inc. - Common Stock |
157 |
$106.95 |
$16,791.15 |
| 23-03-2022 |
de Jonge Investments |
Karyopharm Therapeutics Inc. - Common Stock |
-157 |
$111.90 |
-$17,568.30 |
